Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders

Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders

Source: 
CP Wire
snippet: 

Numerate, Inc. announced on 1/7/19 a multi-target research collaboration with Lundbeck Pharmaceutical to identify clinical candidates for the treatment of disorders in the central nervous system, including depression, psychosis, seizure and neurodegenerative disorders.